# Promakhos Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/promakhos-therapeutics

- Industry: Biotechnology
- Headquarters: US
- Website: www.promakhos.com
- Latest round: Seed (Jul 1, 2021)
- Investors on record: 1

## About

Based in Massachusetts, US, and founded in 2021 by Katerina Chatzi (CEO) and Jasper E. Neggers (CSO), Promakhos Therapeutics, Inc. operates as a biotechnology research company that develops cures and therapies for various inflammatory disorders. The firm’s partners include Y Combinator, Harvard Innovation Labs, Metaplanet, Mass Bio, Morrison Foerster, etc.



The firm develops curative therapies by building a platform of bacterial molecules that help restore the functions of the innate immune system and understand the root cause of the inflammation, allowing the inflamed body to control inflammation and heal. The firm develops therapies that aim to treat chronic inflammatory diseases such as Crohn’s disease, multiple sclerosis, and ankylosing spondylitis.

## Funding rounds

- Seed, Jul 1, 2021 — Pioneer Fund

## Investors

- Pioneer Fund (https://capitalatlas.ai/funds/pioneer-fund) — Seed